Moreover, the administration of CH-223191 led to the failure of mBD-14 to improve TJ barrier function in AD mice, thus indicating that AhR is required for the mBD-14–mediated improvements in AD mice (Figure 7D). The gene discussed is AHR; the disease is Alzheimer disease.